Educational Background
| 1. |
2004/03
Degree Acquisition
|
,
|
|
Research Field (Keyword)
|
Clinical pharmacy (Key Word：Pharmaceutical Technology, Drug Delivery System)
|
|
Work experience /Academic appointments
|
1.
|
1996/09～2006/03
|
Tokyo University of Pharmacy and Life Sciences School of Pharmacy Research associate
|
|
2.
|
2006/04～2017/09
|
Matsuyama university College of Pharmaceutical Sciences Lecturer
|
|
3.
|
2017/10～2021/09
|
Matsuyama university College of Pharmaceutical Sciences Associate Professor
|
|
4.
|
2021/10～
|
Matsuyama University College of Pharmaceutical Sciences Professor
|
|
Membership of Professional Organizations
|
1.
|
2006/04～
|
The Society of powder Technology, Japan
|
|
2.
|
2015/09～
|
American Association of Pharmaceutical Scientists
|
|
Publications
|
1.
|
2025/05
|
Article
|
Effect of particle size of powdered cellulose nanofibers as an additive in the production of orally disintegrating mini-tablets by direct powder compression Chem. Pharm. Bull. 73(5),pp.467-477 (Collaboration)
|
|
2.
|
2023/12
|
Article
|
Effect of Powdered Cellulose Nanofiber with Different Particle Sizes on the Physical Properties of Tablets Manufactured via Direct Compression Chem. Pharm. Bull. 71(12),pp.887-896 (Collaboration)
|
|
3.
|
2023/09
|
Article
|
Effects of Granulated Lactose Characteristics and Lubricant Blending Conditions on Tablet Physical Properties in Direct Powder Compression Chem. Pharm. Bull. 71(9),pp.687-694 (Collaboration)
|
|
4.
|
2022/09
|
Article
|
The Effect of Cellulose Nanofibers on the Manufacturing of Mini-Tablets by Direct Powder Compression Chem. Pharm. Bull. 70(9),pp.628-638 (Collaboration)
|
|
5.
|
2022/01
|
Article
|
Orally Disintegrating Tablet Manufacture via Direct Powder Compression Using Cellulose Nanofiber as a Functional Additive AAPS PharmSciTech 23 (Collaboration)
|
|
6.
|
2019/08
|
Article
|
Utility of Microcrystalline Cellulose to Prevent Drug Segregation in Direct Powder Compression Journal of Drug Delivery Science and Technology 52,pp.386-392 (Collaboration)
|
|
7.
|
2019/04
|
Article
|
Utility of Microcrystalline Cellulose for Improving Drug Content Uniformity in Tablet Manufacturing Using Direct Powder Compression AAPS PharmSciTech 20(4) (Collaboration)
|
|
8.
|
2019/03
|
Article
|
Potential Use of Magnesium Oxide as an Excipient to Maintain the Hardness of Orally Disintegrating Tablets during Unpackaged Storage Chem. Pharm. Bull. 67(3),pp.284-288 (Collaboration)
|
|
9.
|
2018/04
|
Article
|
Preparation of Controlled-Release Particles Based on Spherical Porous Silica Used as the Drug Carrier by the Dry Coating Method AAPS PharmSciTech 19(3),pp.1493-1499 (Collaboration)
|
|
10.
|
2017/10
|
Article
|
Setting ideal lubricant mixing time for manufacturing tablets by evaluating powder flowability AAPS PharmSciTech 18(7),pp.2832-2840 (Collaboration)
|
|
11.
|
2017/05
|
Article
|
Evaluation of Sucrose Fatty Acid Esters as Lubricants in Tablet Manufacturing Chem. Pharm. Bull. 65(5),pp.432-441 (Collaboration)
|
|
12.
|
2016/12
|
Article
|
Preparation of Controlled-Release Fine Particles Using a Dry Coating Method AAPS PharmSciTech 17(6),pp.1393-1403 (Collaboration)
|
|
13.
|
2016/09
|
Article
|
Mechanism by which magnesium oxide suppresses tablet hardness reduction during storage Chem. Pharm. Bull. 64(9),pp.1256-1261 (Collaboration)
|
|
14.
|
2016/05
|
Article
|
Predicting the occurrence of sticking during tablet production by shear testing of a pharmaceutical powder Chem. Pharm. Bull. 64(5),pp.512-516 (Collaboration)
|
|
15.
|
2013/11
|
Other
|
Preparation of taste-masked particles with immediate-release property using an ultrahigh-speed mixer PHARM TECH JAPAN pp.115-121 (Single)
|
|
16.
|
2011/11
|
Article
|
The inhibitory effect of magnesium oxide on hardness loss in unpacked tablets Journal of Pharmaceutical Science and Technology, Japan (Collaboration)
|
|
17.
|
2006/04
|
Article
|
Induction of cancer cell-specific apoptosis by folate-labeled cationic liposomes J. Control. Release pp.325-332 (Collaboration)
|
|
18.
|
2006/02
|
Article
|
Changes in immune responses to mite antigen sensitized through barrier-disrupted skin with CpG-oligodeoxynucleotide in mice Biol Pharm Bull. pp.385-387 (Collaboration)
|
|
19.
|
2005/11
|
Article
|
Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in mice J. Control. Release pp.294-305 (Collaboration)
|
|
20.
|
2005/05
|
Article
|
Selective and Enhanced Transgene Expression in Hepatocellular Carcinoma Cells by Asialofetuin-labeled Liposome and AFP Promoter J. Drug Del. Tech. Sci. pp.195-200 (Collaboration)
|
|
21.
|
2004/11
|
Article
|
Improvement of Dermatitis by Iontophoretically Delivered Antisense Oligonucleotides for Interleukin-10 in NC/Nga Mice Gene Ther. pp.317-324 (Collaboration)
|
|
22.
|
2003/10
|
Article
|
Intradermal Delivery of Antisense Oligonucleotides by the Pulse Depolarization Iontophoretic System Biol. Pharm. Bull. pp.1461-1466 (Collaboration)
|
|
23.
|
2003/03
|
Article
|
Efficient Gene Transfer to Hepatoblastoma Cells through Asialoglycoprotein Receptor and Expression under the Control of the Cyclin A Promoter Biol. Pharm. Bull. pp.357-360 (Collaboration)
|
|
24.
|
1999/08
|
Article
|
Design of Potent Phosphorothioate Antisense Oligonucleotides Directed to Human Interleukin 10 Gene Product and Their Evaluation of Antisense Activity in U937Cells Pharm. Res. pp.1163-1171 (Collaboration)
|
|
25.
|
1998/08
|
Article
|
Specific Inhibition of Interleukin-10 Production in Murine Macrophage-like Cells by Phosphorothioate Antisense Oligonucleotides Antisense Nucleic Acid Drug Dev. pp.319-327 (Collaboration)
|
|
26.
|
1997/10
|
Article
|
Specific Inhibition of Nitric Oxide Production in Macrophages by Phosphorothioate Antisense Oligonucleotides J.Pharm.Sci. pp.1079-1084 (Collaboration)
|
|
Display 5 items
|
|
Display all(26)
|
|
Faculty Information
